Emergent BioSolutions Reports Financial Results for Fourth Quarter 2022
February 27, 2023 16:42 ET
|
Emergent BioSolutions
Reports Q4 2022 total revenues of $331M resulting in FY 2022 total revenues of $1,121M, in line with prior guidanceReports Q4 2022 net loss of $88M and FY 2022 net loss of $224MReports Q4 2022...
Emergent BioSolutions Reports Financial Results For Third Quarter 2021
November 04, 2021 16:05 ET
|
Emergent BioSolutions
GAITHERSBURG, Md., Nov. 04, 2021 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today reported financial results for the third quarter ended September 30, 2021. "Emergent's core...
Emergent BioSolutions Reports Financial Results for Fourth Quarter and Full Year 2020
February 18, 2021 16:05 ET
|
Emergent BioSolutions
Reports record fourth quarter and year to date 2020 performance, in line with prior guidanceReaffirms full year 2021 forecast GAITHERSBURG, Md., Feb. 18, 2021 (GLOBE NEWSWIRE) --...
Emergent BioSolutions Reports Financial Results for Fourth Quarter and Full Year 2019
February 20, 2020 16:31 ET
|
Emergent BioSolutions
GAITHERSBURG, Md., Feb. 20, 2020 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) reported financial results for the quarter and year ended December 31, 2019. FINANCIAL HIGHLIGHTS (in...
Emergent BioSolutions Reports Third Quarter and Nine Months 2017 Financial Results; Raises Calendar Year 2017 Guidance
November 02, 2017 16:15 ET
|
Emergent Biosolutions, Inc.
GAITHERSBURG, Md., Nov. 02, 2017 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) reported financial results for the quarter and nine months ended September 30, 2017. FINANCIAL HIGHLIGHTS ...
Emergent BioSolutions Reports Second Quarter and Six Months 2017 Financial Results; Reaffirms Calendar Year 2017 Guidance
August 03, 2017 16:15 ET
|
Emergent BioSolutions Inc.
GAITHERSBURG, Md., Aug. 03, 2017 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) reported financial results for the quarter and six months ended June 30, 2017. FINANCIAL HIGHLIGHTS (in...
Emergent BioSolutions to Release Second Quarter 2017 Financial Results and Conduct a Conference Call on August 3, 2017
July 20, 2017 07:00 ET
|
Emergent BioSolutions Inc.
GAITHERSBURG, Md., July 20, 2017 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) will release its second quarter financial results immediately after market close on Thursday, August 3,...
Emergent BioSolutions Reports Fourth Quarter and Twelve Months 2016 Financial Results; Reaffirms 2017 Guidance and Provides 2020 Goals
February 23, 2017 16:15 ET
|
Emergent BioSolutions Inc.
GAITHERSBURG, Md., Feb. 23, 2017 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) reported financial results for the quarter and twelve months ended December 31, 2016. 2016 FINANCIAL...
Emergent BioSolutions Reports Third Quarter and Nine Months 2016 Financial Results
November 07, 2016 16:15 ET
|
Emergent BioSolutions Inc.
GAITHERSBURG, Md., Nov. 07, 2016 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) reported financial results for the quarter and nine months ended September 30, 2016. FINANCIAL...
Emergent BioSolutions Reports Second Quarter and Six Months 2016 Financial Results
August 04, 2016 16:15 ET
|
Emergent BioSolutions Inc.
GAITHERSBURG, Md., Aug. 04, 2016 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) reported financial results for the quarter and six months ended June 30, 2016. FINANCIAL HIGHLIGHTS ...